STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex AB (STO:ALNX): Tulane University Hospital, New Orleans, LA, USA will in May start a prospective trial in Kidney Transplantation investigating the potential of cross match XM-ONE® as part of the risk assessment of their patients.
